🆚 MovieAds vs. myTarget

Compare technologies based on real-world usage data *

Type

Advertising technology
Advertising technology

About

MovieAds is a Russian video advertising network that helps website owners monetise traffic by serving video ads and paying for impressions rather than clicks.

It offers branded video ad formats such as Autoplay, Flyroll, Preloader, and Preroll, supports personalised campaign delivery, and works with advertisers from Russia, the CIS, and Europe.

MyTarget is a Russian programmatic advertising platform by VK.

Headquarters

Saint Petersburg, Russia
Moscow, Russia

Website

Categories

Advertising › Rank #166
Advertising › Rank #119

Popularity

Determined by the number of sites using each technology.

MyTarget advertising technology is 3 times more popular than MovieAds.
Total websites

Market share

Advertising

Popularity by country

Determined by the number of sites detected from each country.

myTarget is more popular in Russia, Kazakhstan, and Belarus, while MovieAds is more popular in the Netherlands, Estonia, and Moldova.
Russia
Kazakhstan
Netherlands
Belarus
Poland
Estonia
France
Germany
Italy
Moldova

Awards

Popularity by domain category

Determined by the number of sites in each category.

myTarget is more popular among sites focused on blogs and wiki, entertainment, and general news, while MovieAds is more commonly used on games, potentially unwanted programs, and education and reference sites.
Blogs/Wiki
Entertainment
General News
Auctions/Classifieds
Marketing/Merchandising
Portal Sites
Real Estate
Public Information
Online Shopping
Business

Top sites

Top-ranked sites that use these technologies.

Name
Rank
#7,387
#40,370
#47,220
#47,462
View more ➝
Name
Rank
#123
#295
#1,445
View more ➝

See also

* According to recent studies, many of online reviews are fake.
When making your decision, it is better to rely on data that cannot be falsified.
Our service evaluates the popularity of technologies by the number of websites using them.

Statistics were last calculated on .
For details, see our methodology and disclaimer.